Overview

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)

Status:
Terminated

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study was to evaluate the long term safety and tolerability of peginesatide for the maintenance of hemoglobin in participants with chronic kidney disease (CKD) who had received at least 24 weeks of peginesatide treatment in an earlier study.

Phase:

Phase 2

Details

Lead Sponsor:

Affymax

Treatments:

Hematinics